Gastroprotectant drugs are used for the prevention and treatment of peptic ulcer disease and might reduce its associated complications, but reliable estimates of the effects of gastroprotectants in different clinical settings are scarce. We aimed to examine the effects of proton-pump inhibitors (PPIs), prostaglandin analogues, and histamine-2 receptor antagonists (H2RAs) in different clinical circumstances by doing meta-analyses of tabular data from all rele...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Elsevier: Lancet Publisher's website
- Lancet Gastroenterology and Hepatology Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Paper number:
- Copyright holder:
- Scally et al.
- Copyright date:
- © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Open access funded by the Medical Research Council.
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: meta-analysis of randomised trials
If you are the owner of this record, you can report an update to it here: Report update to this record